{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:54:40Z","timestamp":1791590080349,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.ajo.2007.11.010","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T17:58:14Z","timestamp":1204826294000},"page":"487-492.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Retrospective Review of Methotrexate Therapy in the Treatment of Chronic, Noninfectious, Nonnecrotizing Scleritis"],"prefix":"10.1016","volume":"145","author":[{"given":"Adrian W.","family":"Jachens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2007.11.010_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.iio.0000155900.64809.b2","article-title":"The diagnosis and management of anterior scleritis","volume":"45","author":"Albini","year":"2005","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ajo.2007.11.010_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0161-6420(99)90157-4","article-title":"Severity of episcleritis and systemic disease association","volume":"106","author":"Akpek","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.11.010_bib3","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0161-6420(99)00719-8","article-title":"Scleritis: a clinicopathologic study of 55 cases","volume":"106","author":"Riono","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.11.010_bib4","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.semarthrit.2004.05.002","article-title":"Intraocular inflammation in autoimmune diseases","volume":"34","author":"Pras","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ajo.2007.11.010_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.11.010_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00130832-200210000-00011","article-title":"Immunomodulatory therapy for anterior segment ocular inflammation","volume":"2","author":"Reed","year":"2002","journal-title":"Curr Opin in Allergy Clin Immunol"},{"key":"10.1016\/j.ajo.2007.11.010_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00055735-200312000-00014","article-title":"Use of immunosuppressive agents in uveitis","volume":"14","author":"Lustig","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2007.11.010_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/092739490500192","article-title":"A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation","volume":"12","author":"Gaudio","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2007.11.010_bib9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.11.010_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/1529-0131(199803)41:3<381::AID-ART2>3.0.CO;2-3","article-title":"The use of methotrexate in childhood rheumatic diseases","volume":"41","author":"Wallace","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajo.2007.11.010_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7326\/0003-4819-103-4-489","article-title":"Weekly pulse methotrexate in rheumatoid arthritis","volume":"103","author":"Anderson","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajo.2007.11.010_bib12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.1780280702","article-title":"Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis","volume":"28","author":"Williams","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajo.2007.11.010_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.1780270403","article-title":"Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis","volume":"27","author":"Willkens","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajo.2007.11.010_bib14","first-page":"581","article-title":"Methotrexate for systemic lupus erythematosus: a retrospective analysis of 17 unselected cases","volume":"9","author":"Wilke","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ajo.2007.11.010_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1191\/096120301666080831","article-title":"Methotrexate therapy in systemic lupus erythematosus","volume":"10","author":"Sato","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.ajo.2007.11.010_bib16","first-page":"1275","article-title":"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus","volume":"26","author":"Carneiro","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajo.2007.11.010_bib17","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","article-title":"Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis","volume":"43","author":"Woo","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajo.2007.11.010_bib18","first-page":"142","article-title":"Low-dose methotrexate treatment in noninfectious uveitis resistant to corticocorticosteroids","volume":"1","author":"Holz","year":"1992","journal-title":"Ger J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.11.010_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0022-3476(98)70232-X","article-title":"Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis","volume":"133","author":"Weiss","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajo.2007.11.010_bib20","first-page":"362","article-title":"Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Foeldvari","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajo.2007.11.010_bib21","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bjo.2004.054239","article-title":"The use of low-dose methotrexate in children with chronic anterior and intermediate uveitis","volume":"89","author":"Malik","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2007.11.010_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1076\/ocii.9.1.35.3983","article-title":"Use of methotrexate in the management of sight-threatening uveitis","volume":"9","author":"Bom","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2007.11.010_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(99)90011-8","article-title":"Methotrexate treatment for sarcoid-associated panuveitis","volume":"106","author":"Dev","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.11.010_bib24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.11.010_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1076\/ocii.11.2.131.15919","article-title":"Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis","volume":"11","author":"Kaplan-Messas","year":"2003","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2007.11.010_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/ar419","article-title":"Molecular action of methotrexate in inflammatory diseases","volume":"4","author":"Chan","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.ajo.2007.11.010_bib27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2004.09.001","article-title":"The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules","volume":"114","author":"Johnston","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ajo.2007.11.010_bib28","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/1529-0131(199811)41:11<2032::AID-ART19>3.0.CO;2-J","article-title":"Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes","volume":"41","author":"Seitz","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajo.2007.11.010_bib29","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/34.7.602","article-title":"Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells","volume":"34","author":"Seitz","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.ajo.2007.11.010_bib30","first-page":"224","article-title":"Interleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low-dose oral methotrexate","volume":"22","author":"Crilly","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajo.2007.11.010_bib31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic antagonist, 4-aminperoyl-glutamic acid (aminopterin)","volume":"238","author":"Farber","year":"1948","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2007.11.010_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000441-195102000-00008","article-title":"Therapeutic suppression of tissue reactivity. I","volume":"221","author":"Gubner","year":"1951","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ajo.2007.11.010_bib33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00000441-195102000-00009","article-title":"Therapeutic suppression of tissue reactivity. II","volume":"221","author":"Gubner","year":"1951","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ajo.2007.11.010_bib34","first-page":"760","article-title":"A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis","volume":"11","author":"Thompson","year":"1984","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajo.2007.11.010_bib35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198503283121303","article-title":"Efficacy of low-dose methotrexate in rheumatoid arthritis","volume":"312","author":"Weinblatt","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2007.11.010_bib36","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0161-6420(92)31790-7","article-title":"Low-dose methotrexate therapy for ocular inflammatory disease","volume":"99","author":"Shah","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2007.11.010_bib37","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0161-6420(03)01004-2","article-title":"Safe and effective","volume":"110","author":"Schachat","year":"2003","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939407009804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939407009804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:57:09Z","timestamp":1757595429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939407009804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0002939407009804"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2007.11.010","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective Review of Methotrexate Therapy in the Treatment of Chronic, Noninfectious, Nonnecrotizing Scleritis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2007.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}